ICL Israel Chemicals Ltd (ICL)
Official siteBASIC MATERIALS • AGRICULTURAL INPUTS • NYSE
Market Cap: $6.03B
Last updated: Nov 17, 2026 at 11:06 AM ET
ICL Israel Chemicals Ltd (ICL) Valuation Multiples
ICL Israel Chemicals (ICL) trades at 0.7x sales and 0.9x book value. Its P/S of 0.7x is below its 5-year median of 1.0x. Its forward P/E is 55.6x.
Current Multiples
Its enterprise value is 5.4x its EBITDA. Its free cash flow yield is 4.0%.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 55.6x |
| Price to sales | 0.7x |
| Price to book | 0.9x |
| EV/EBITDA | 5.4x |
| Price to FCF | 24.8x |
| EV/FCF | 36.9x |
| PEG | N/A |
| FCF yield | 4.0% |
Historical Medians
Against its 10-year medians, its P/S is 30.0% below 1.0x and its P/B is 43.8% below 1.6x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | N/A | 10.9x | 12.9x |
| P/S | 0.7x | 1.0x | 1.0x |
| P/B | 0.9x | 1.3x | 1.6x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 4.0x in 2022 to 24.0x in 2020.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $5.71 | 15.4x | 1.0x | 1.2x |
| 2024 | $4.94 | 13.0x | 0.9x | 1.1x |
| 2023 | $5.01 | 8.8x | 0.9x | 1.1x |
| 2022 | $7.31 | 4.0x | 0.9x | 1.7x |
| 2021 | $9.67 | 14.9x | 1.8x | 2.8x |
| 2020 | $5.05 | 24.0x | 1.3x | 1.6x |
| 2019 | $4.79 | 12.6x | 1.2x | 1.6x |
| 2018 | $5.66 | 15.3x | 1.3x | 1.9x |
| 2017 | $4.04 | 13.5x | 1.0x | 1.8x |
| 2016 | $4.11 | 11.7x | 1.0x | 2.0x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ICL
What is ICL's forward P/E ratio?
ICL Israel Chemicals has a forward P/E ratio of 55.6x.
Is ICL stock overvalued?
GNG's valuation label for ICL is Fairly valued.
What is ICL's price to sales ratio?
ICL Israel Chemicals has a price to sales ratio of 0.7x.
What is ICL Israel Chemicals's average P/E ratio over 5 years?
ICL Israel Chemicals's median P/E over the last 5 years is 10.9x, from 56 month-end values through Oct 2026.
ICL pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors